Psigryph Inc.
PrivateLast Round
Accelerator
Nov 3, 2024
Total Funding Raised
$123,000
Company Overview
Psigryph Inc. operates in Healthcare & Life Sciences and is based in Guelph. Its latest recorded funding round was an Accelerator round in November 2024.
Psigryph Inc. is a biotechnology company that develops a patented, plant-derived nanodelivery system called Nanopect™ to enhance the bioavailability of bioactive molecules across cell membranes for applications in agriculture, food, and pharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Psigryph Inc. Comparables
Compare Psigryph Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nucaps Nanotechnology | 79% | |
| Ascension Sciences | 70% | |
| AgroSpheres | 65% |
For institutional investors. Book with your work email.
Psigryph Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 3, 2024 | ||||
| Grant | Aug 29, 2022 | ||||
| Grant | Aug 4, 2022 | ||||
| Accelerator | May 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Psigryph Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HudsonAlpha Institute for Biotechnology | Accelerator |
| Sustainable Development Technology Canada | Grant |
| gener8tor | Accelerator |
| i.d.e.a. Fund | Grant |
| Boundless Accelerator | Grant |
| MassChallenge Switzerland | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2026
Monthly visitors grew 331% MoM, from 357 to 1.5K.
- Nov 3, 2024
$100K raised from gener8tor and HudsonAlpha Institute.
For institutional investors. Book with your work email.
Psigryph Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Psigryph Inc.'s valuation, stock price, and market status.
Is Psigryph Inc. a public or private company?
Psigryph Inc. is a private company.
What is the current stock price of Psigryph Inc.?
Psigryph Inc. is a private company, so its shares have no public market price. Caplight tracks Psigryph Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Psigryph Inc. worth (valuation)?
Valuation information for Psigryph Inc. is not publicly available.
Can I buy Psigryph Inc. stock?
Psigryph Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Psigryph Inc.'s last funding round?
Psigryph Inc.'s most recent funding round was Accelerator on November 3, 2024.
Who are the main investors in Psigryph Inc.?
Key investors in Psigryph Inc. include HudsonAlpha Institute for Biotechnology, Sustainable Development Technology Canada, gener8tor, i.d.e.a. Fund, Boundless Accelerator.
Will Psigryph Inc. IPO soon?
No public IPO plans have been announced for Psigryph Inc..
How can I track Psigryph Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Psigryph Inc.'s shares on secondary markets.